Katherine Gorrell, a seasoned healthcare professional, joins BioStem Technologies to lead legal and compliance efforts for an upcoming Nasdaq uplisting. Meanwhile, LakeShore Biopharma announces an amended merger agreement with Oceanpine Skyline Inc., aiming for a going-private transaction valued at approximately US$2.7 million.
